Skip to main content

Oric Pharmaceuticals, Inc.

ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001796280

In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding Oric Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ORIC: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders7664−12
Shares32.7M32.4M−273.1K (−0.8%)
Value$104.6M$192.1M+$87.5M (+83.6%)

New holders (6)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ORIC in Q4 2022
InstitutionSharesValue% of portfolio
EAM Investors, LLC190,455$1.12M0.23%
Bank of Montreal107,688$635.9K0.00%
683 Capital Management, LLC33,800$199.1K0.02%
Boothbay Fund Management, LLC11,228$66.1K0.00%
Man Group plc11,209$66.0K0.00%
Pensionmark Financial Group, LLC10,700$63.0K0.01%

Sold out (18)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.